276 related articles for article (PubMed ID: 16883148)
21. Ramelteon: a novel treatment for the treatment of insomnia.
Wurtman R
Expert Rev Neurother; 2006 Jul; 6(7):957-64. PubMed ID: 16831111
[TBL] [Abstract][Full Text] [Related]
22. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
Srinivasan V; Zakaria R; Othaman Z; Brzezinski A; Prasad A; Brown GM
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
[TBL] [Abstract][Full Text] [Related]
23. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
[TBL] [Abstract][Full Text] [Related]
24. A survey of the effects of ramelteon on benzodiazepine-dependence: Comparison between a ramelteon add-on group and a continuous benzodiazepine administration group.
Naono-Nagatomo K; Abe H; Araki R; Funahashi H; Takeda R; Taniguchi H; Ishida Y
Asian J Psychiatr; 2018 Aug; 36():20-24. PubMed ID: 29886401
[TBL] [Abstract][Full Text] [Related]
25. [Delirium, insomnia in hospitalization and ramelteon].
Ito T
Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020
[TBL] [Abstract][Full Text] [Related]
26. Melatonergic drugs in clinical practice.
Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
[TBL] [Abstract][Full Text] [Related]
27. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
Srinivasan V; Brzezinski A; Pandi-Perumal SR; Spence DW; Cardinali DP; Brown GM
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):913-23. PubMed ID: 21453740
[TBL] [Abstract][Full Text] [Related]
28. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
[TBL] [Abstract][Full Text] [Related]
29. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
Wang-Weigand S; Watissée M; Roth T
Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
[TBL] [Abstract][Full Text] [Related]
30. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
Quera-Salva MA; Claustrat B
Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
[TBL] [Abstract][Full Text] [Related]
31. [A novel therapeutic drug: ramelteon].
Miyamoto M
Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
[TBL] [Abstract][Full Text] [Related]
32. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
Roth T; Seiden D; Wang-Weigand S; Zhang J
Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067
[TBL] [Abstract][Full Text] [Related]
33. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
Mini LJ; Wang-Weigand S; Zhang J
Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.
Gooneratne NS; Gehrman P; Gurubhagavatula I; Al-Shehabi E; Marie E; Schwab R
J Clin Sleep Med; 2010 Dec; 6(6):572-80. PubMed ID: 21206546
[TBL] [Abstract][Full Text] [Related]
35. A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder.
Norris ER; Karen Burke ; Correll JR; Zemanek KJ; Lerman J; Primelo RA; Kaufmann MW
J Affect Disord; 2013 Jan; 144(1-2):141-7. PubMed ID: 22963894
[TBL] [Abstract][Full Text] [Related]
36. Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.
Uchiyama M; Hamamura M; Kuwano T; Nagata H; Hashimoto T; Ogawa A; Uchimura N
Sleep Med; 2011 Feb; 12(2):127-33. PubMed ID: 21277255
[TBL] [Abstract][Full Text] [Related]
37. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].
Mishima K
Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618
[TBL] [Abstract][Full Text] [Related]
38. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
Erman M; Seiden D; Zammit G; Sainati S; Zhang J
Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
[TBL] [Abstract][Full Text] [Related]
39. Melatonin agonists and insomnia.
Ferguson SA; Rajaratnam SM; Dawson D
Expert Rev Neurother; 2010 Feb; 10(2):305-18. PubMed ID: 20136385
[TBL] [Abstract][Full Text] [Related]
40. Ramelteon: profile of a new sleep-promoting medication.
Owen RT
Drugs Today (Barc); 2006 Apr; 42(4):255-63. PubMed ID: 16703122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
